BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26307083)

  • 1. Muscle weakness in TPM3-myopathy is due to reduced Ca2+-sensitivity and impaired acto-myosin cross-bridge cycling in slow fibres.
    Yuen M; Cooper ST; Marston SB; Nowak KJ; McNamara E; Mokbel N; Ilkovski B; Ravenscroft G; Rendu J; de Winter JM; Klinge L; Beggs AH; North KN; Ottenheijm CA; Clarke NF
    Hum Mol Genet; 2015 Nov; 24(22):6278-92. PubMed ID: 26307083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a R133W beta-tropomyosin mutation on regulation of muscle contraction in single human muscle fibres.
    Ochala J; Li M; Tajsharghi H; Kimber E; Tulinius M; Oldfors A; Larsson L
    J Physiol; 2007 Jun; 581(Pt 3):1283-92. PubMed ID: 17430991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in cross-bridge cycling underlie muscle weakness in patients with tropomyosin 3-based myopathy.
    Ottenheijm CA; Lawlor MW; Stienen GJ; Granzier H; Beggs AH
    Hum Mol Genet; 2011 May; 20(10):2015-25. PubMed ID: 21357678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease severity and thin filament regulation in M9R TPM3 nemaline myopathy.
    Ilkovski B; Mokbel N; Lewis RA; Walker K; Nowak KJ; Domazetovska A; Laing NG; Fowler VM; North KN; Cooper ST
    J Neuropathol Exp Neurol; 2008 Sep; 67(9):867-77. PubMed ID: 18716557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Primary Causes of Muscle Dysfunction Associated with the Point Mutations in Tpm3.12; Conformational Analysis of Mutant Proteins as a Tool for Classification of Myopathies.
    Borovikov YS; Karpicheva OE; Simonyan AO; Avrova SV; Rogozovets EA; Sirenko VV; Redwood CS
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital myopathy-related mutations in tropomyosin disrupt regulatory function through altered actin affinity and tropomodulin binding.
    Moraczewska J; Robaszkiewicz K; Śliwinska M; Czajkowska M; Ly T; Kostyukova A; Wen H; Zheng W
    FEBS J; 2019 May; 286(10):1877-1893. PubMed ID: 30768849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tropomyosin in the groove? Molecular insights into an inherited myopathy.
    Chase PB
    J Physiol; 2007 Jun; 581(Pt 3):889. PubMed ID: 17525111
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for a dominant negative disease mechanism in cap myopathy due to TPM3.
    Waddell LB; Kreissl M; Kornberg A; Kennedy P; McLean C; Labarre-Vila A; Monnier N; North KN; Clarke NF
    Neuromuscul Disord; 2010 Jul; 20(7):464-6. PubMed ID: 20554445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TPM3 deletions cause a hypercontractile congenital muscle stiffness phenotype.
    Donkervoort S; Papadaki M; de Winter JM; Neu MB; Kirschner J; Bolduc V; Yang ML; Gibbons MA; Hu Y; Dastgir J; Leach ME; Rutkowski A; Foley AR; Krüger M; Wartchow EP; McNamara E; Ong R; Nowak KJ; Laing NG; Clarke NF; Ottenheijm C; Marston SB; Bönnemann CG
    Ann Neurol; 2015 Dec; 78(6):982-994. PubMed ID: 26418456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Mechanisms of the Deregulation of Muscle Contraction Induced by the R90P Mutation in Tpm3.12 and the Weakening of This Effect by BDM and W7.
    Borovikov YS; Andreeva DD; Avrova SV; Sirenko VV; Simonyan AO; Redwood CS; Karpicheva OE
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanisms of Deregulation of Muscle Contractility Caused by the R168H Mutation in TPM3 and Its Attenuation by Therapeutic Agents.
    Karpicheva OE; Avrova SV; Bogdanov AL; Sirenko VV; Redwood CS; Borovikov YS
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular mechanisms of a high Ca
    Avrova SV; Karpicheva OE; Simonyan AO; Sirenko VV; Redwood CS; Borovikov YS
    Biochem Biophys Res Commun; 2019 Jul; 515(2):372-377. PubMed ID: 31155291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanisms of Muscle Weakness Associated with E173A Mutation in Tpm3.12. Troponin Ca
    Borovikov YS; Simonyan AO; Avrova SV; Sirenko VV; Redwood CS; Karpicheva OE
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32580284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Variant in
    Robaszkiewicz K; Siatkowska M; Wadman RI; Kamsteeg EJ; Chen Z; Merve A; Parton M; Bugiardini E; de Bie C; Moraczewska J
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myopathy-causing Q147P TPM2 mutation shifts tropomyosin strands further towards the open position and increases the proportion of strong-binding cross-bridges during the ATPase cycle.
    Karpicheva OE; Simonyan AO; Kuleva NV; Redwood CS; Borovikov YS
    Biochim Biophys Acta; 2016 Mar; 1864(3):260-267. PubMed ID: 26708479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional effects of congenital myopathy-related mutations in gamma-tropomyosin gene.
    Robaszkiewicz K; Dudek E; Kasprzak AA; Moraczewska J
    Biochim Biophys Acta; 2012 Oct; 1822(10):1562-9. PubMed ID: 22749829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies.
    Marttila M; Lehtokari VL; Marston S; Nyman TA; Barnerias C; Beggs AH; Bertini E; Ceyhan-Birsoy O; Cintas P; Gerard M; Gilbert-Dussardier B; Hogue JS; Longman C; Eymard B; Frydman M; Kang PB; Klinge L; Kolski H; Lochmüller H; Magy L; Manel V; Mayer M; Mercuri E; North KN; Peudenier-Robert S; Pihko H; Probst FJ; Reisin R; Stewart W; Taratuto AL; de Visser M; Wilichowski E; Winer J; Nowak K; Laing NG; Winder TL; Monnier N; Clarke NF; Pelin K; Grönholm M; Wallgren-Pettersson C
    Hum Mutat; 2014 Jul; 35(7):779-90. PubMed ID: 24692096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of tropomyosin function and folding by a nemaline myopathy-causing mutation.
    Moraczewska J; Greenfield NJ; Liu Y; Hitchcock-DeGregori SE
    Biophys J; 2000 Dec; 79(6):3217-25. PubMed ID: 11106625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and biological activity of Baculovirus generated wild-type human slow alpha tropomyosin and the Met9Arg mutant responsible for a dominant form of nemaline myopathy.
    Akkari PA; Song Y; Hitchcock-DeGregori S; Blechynden L; Laing N
    Biochem Biophys Res Commun; 2002 Aug; 296(2):300-4. PubMed ID: 12163017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel TPM3 mutation in a family with cap myopathy and review of the literature.
    Schreckenbach T; Schröder JM; Voit T; Abicht A; Neuen-Jacob E; Roos A; Bulst S; Kuhl C; Schulz JB; Weis J; Claeys KG
    Neuromuscul Disord; 2014 Feb; 24(2):117-24. PubMed ID: 24239060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.